Curaleaf Sees Grassroots Shareholders Approve Transaction

Curaleaf Holdings (CSE: CURA) announced this morning that the shareholders of GR Companies, known as Grassroots, have approved of the transaction that will see the firm vend into the public company. It was stated that over 87% of existing shareholders approved of the transaction.

Further, Mitchell Kahn, whom is the co-founder and CEO of Grassroots, indicated that zero “no” votes were received from the shareholders of the company, indicating a high rate of approval to go forward with the transaction. The transaction as a result is now expected to close early next week.

Originally announced on July 17, 2019 – exactly one year ago today – the original definitive agreement was to see Grassroots shareholders receive 102.8 million subordinate voting shares of Curaleaf, in addition to a cash component of $75 million. That agreement however was modified last month, with the cash component removed from the transaction in the face of a cannabis capital markets liquidity crunch. Instead, the company is now expected to issue approximately 118.9 million shares of Curaleaf, equity to roughly 18% on a pro-forma basis.

The closing of the transaction as a whole will follow the announcement earlier this week that certain Arizona assets have already been transferred from that of Grassroots to Curaleaf.

Curaleaf Holdings last traded at $9.65 on the CSE.


Information for this briefing was found via Sedar and Curaleaf Holdings. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Moon River Moly: The Davidson Moly-Copper-Tungsten PEA

Integra: The DeLamar Heap Leach Feasibility Study

Highlander Silver: The Saviour Of Bear Creek Mining

Recommended

Steadright Subsidiary NSM Capital Sarl Applies For License At Titanbeach One

Goliath Resources Accelerates Option Agreement On Golddigger While Reducing NSR

Related News

Curaleaf Sees Losses Climb In Q2

Curaleaf Holdings (CSE: CURA) saw mild growth in the second quarter in terms of topline...

Thursday, August 10, 2023, 09:16:48 AM

Curaleaf Closes US$300 Million Senior Secured Loan

Curaleaf Holdings (CSE: CURA) has closed its previously announced term loan facility for an upsized...

Wednesday, January 15, 2020, 08:47:24 AM

Curaleaf Receives Approval For TSX Listing

Curaleaf Holdings (CSE: CURA) is officially leaving the Canadian Securities Exchange. The company has been...

Thursday, December 7, 2023, 08:58:30 AM

Curaleaf Closes European Transaction, Immediately Sells 31.5% Stake To Undisclosed Strategic Investor

Curaleaf Holdings (CSE: CURA) this morning announced the completion of EMMAC Life Sciences, a vertically...

Wednesday, April 7, 2021, 08:38:43 AM

Curaleaf Holdings Hit By FDA Warning Letter

Curaleaf Holdings (CSE: CURA) was slapped by the FDA this morning with a warning letter...

Tuesday, July 23, 2019, 11:54:55 AM